Provision of medical abortion using telemedicine in Brazil

Contraception

Volumn 89, Issue 2, 2014, Pages 129-133

  Gomperts, Rebecca ^a   Van Der Vleuten, Kirsten ^b   Jelinska, Kinga ^c   Da Costa, Cecilia Veiera ^c   Gemzell Danielsson, Kristina ^d   Kleiverda, Gunilla ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Women on Waves   (Netherlands)

^c Women's Wallet   (Netherlands)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Flevoziekenhuis Almere ^*  (Netherlands)

Author keywords

Brazil; E health; Home use; Medical abortion; Mifepristone; Self administration; Sublingual misoprostol; Telemedicine; Women on Web

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CLINICAL PRACTICE; DRUG SELF ADMINISTRATION; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; MEDICAL ABORTION; MIDDLE AGED; PATIENT SAFETY; PREGNANCY TEST; RETROSPECTIVE STUDY; TELEMEDICINE; ULTRASOUND; YOUNG ADULT;

BRAZIL; E-HEALTH; HOME-USE; MEDICAL ABORTION; MIFEPRISTONE; SELF-ADMINISTRATION; SUBLINGUAL MISOPROSTOL; TELEMEDICINE; WOMEN ON WEB;

ABORTION, INDUCED; ADOLESCENT; ADULT; BRAZIL; FEMALE; HUMANS; INTERNET; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; TELEMEDICINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892364142     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.11.005     Document Type: Article

References (18)

1. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008, 3rd ed 2011 World Health Organization Geneva http://whqlibdoc.who.int/publications/2011/9789241501118- eng.pdf accessed November 19 th, 2012
2. Menezes, G, Aquino, EML. Pesquisa sobre o aborto no Brasil: avanços e desafi os para o campo da saúde coletiva [Research on abortion in Brazil: gaps and challenges for the public health field]. Cad. Saúde Pública, 2009;25(2):193-204. (http://www.scielo.br/scielo. php?script=sci-arttext&pid=S0102-311X2009001400002 accessed on November 19 th, 2012).
3. A.C. Guedes Abortion in Brazil: legislation, reality and options Reprod Health Matters 8 16 2000 66 76
4. S. Singh, M. Monteiro, and J. Levin Trends in hospitalization for abortion-related complications in Brazil, 1992-2009: Why the decline in numbers and severity? Int J Gynaecol Obstet 118 Suppl. 2 2012 Sep S99 S106
5. S. Miller et al. Misoprostol and declining abortion related morbidity in Santo Domingo, Dominican Republic: a temporal association Br J Obstet Gynaecol 112 2005 1291 1296
6. L. Briozzo et al. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion Int J Gynecol Obstet 95 2 2006 221 226
7. Letter to UN Human Rights Council, Geneva Switzerland, São Paulo, November 28, 2011. Re: Brazil - 13th Universal Periodic Review session: misoprostol and violation of the right to health and the right to information on sexual and reproductive heath. Periodic universal review, cycle 2, June 2012, Brazil prepared by The Commission for Citizenship and Reproduction (CCR, Comissão de Cidadania e Reprodução). http://www.ohchr.org/EN/ HRBodies/UPR/Pages/BRSession13.aspx accessed November 9th.
8. R. Gomperts et al. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services BJOG 115 2008 1171 1178
9. R. Gomperts et al. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine Acta Obstet Gynecol Scand 91 2012 226 231
10. Royal College of Obstetricians and Gynaecologists The care of women requesting induced abortion. Evidence-based guideline no. 7 2004 RCOG Press London
11. Safe abortion: technical and policy guidance for health systems, Second edition, WHO http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434-eng. pdf 2012 accessed November 19 th, 2012
12. B. Winikoff et al. Extending outpatient medical abortion services through 70 days of gestational age Obstet Gynecol 120 5 2012 Nov 1070 1076
13. H. Wildschut et al. Medical methods for mid-trimester termination of pregnancy Cochrane Database Syst Rev 1 2011 Jan 19 CD005216
14. P.W. Ashok, A. Templeton, P.T. Wagaarachchi, and G.M. Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases BJOG 109 11 2002 Nov 1281 1289
15. S.B. Rose, C. Shand, and A. Simmins Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases Aust N Z J Obstet Gynaecol 46 6 2006 Dec 479 485
16. M. Mentula, and O. Heikinheimo Risk factors of surgical evacuation following second-trimester medical termination of pregnancy Contraception 86 2 2012 Aug 141 146
17. S. Raghavan et al. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol for medical abortion up to 63 days since last menstrual period: evidence from Uzbekistan Eur J Contracept Reprod Health Care 18 2013 104 111
18. S. Raghavan et al. Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trials Eur J Contracept Reprod Health 18 2013 112 119